This study is aimed at investigating the antiplasmodial activity and acute toxicity of the methanol (MeOH) extracts of the leaves and roots, and the dichloromethane (DCM) extracts of the stem bark, leaves, and roots of Goniothalamus lanceolatus. Phytochemical analysis was then carried out on the most active extract. In vivo antiplasmodial activity was assessed using the 4-day suppressive test against Plasmodium berghei ANKA (PbANKA) in mice. The plant extracts were administered intraperitoneally (i.p.) as a single dose (30 mg/kg) starting 4 h after infection. At a dose level of 30 mg/kg (i.p.), the DCM extracts of the stem bark and leaves, and the MeOH root extracts, prolonged the survival period of infected mice compared to that of the negative control. In addition, all crude extracts, except for the DCM root extract, exhibited parasitemia suppressive activity. The highest level of parasitemia suppression was recorded in mice treated with the DCM stem bark extract at 66.3%. No mortality was observed in mice treated with the DCM extracts of the stem bark and leaves, and the MeOH extract of the leaves, indicating that the LD 50 is greater than 300 mg/kg. On the other hand, both the MeOH and DCM extracts of the roots showed toxic effects at a dose of 300 mg/kg (i.p) with an 83.3% mortality rate. The results obtained indicate that the stem bark of G. lanceolatus (DCM crude extract) possesses good antiplasmodial activity against PbANKA infected mice without causing acute toxicity. Five known styrylpyrone derivatives namely goniodiol 1, 8-epi-9-deoxygoniopypyrone 2, 9-deoxygoniopypyrone 3, digoniodiol 4 and goniothalamin 5 have been isolated from the bark of Goniothalamus lanceolatus (DCM crude extract). The structures and stereochemistry of all compounds were elucidated by interpretation of spectroscopic data. This study provides a scientific basis to support the traditional use of the plant as a remedy for malaria.
Malaria remains one of the major threats to public health, with approximately 300-500 million cases, and over one million deaths reported annually [1] . The global burden of this disease is mainly attributed to the emergence of malaria parasites resistant to the existing antimalarial drugs [2] . There is currently no commercially available malaria vaccine, despite many decades of intense research and development effort. Thus, chemotherapeutic agents continue to be in demand for the management of malaria. Yet challenges, such as inevitable resistance to malaria drugs pose a serious threat against malaria control. The rising problem of resistance to the classical drugs (chloroquine and sulphadoxine pyrimethamine), and the problem of recrudescence of artemisinin, warrant the development of new classes of antimalarial agents [3] . Thus, in an effort to overcome and combat the ravages of the disease, attention has been focused on the evaluation of medicinal plants, in the hope that they can provide new and novel antimalarial agents.
Medicinal plants are frequently used to treat diseases where the biodiversity of plants occurs in parallel with endemic transmission of malaria [4] . Tropical rainforest plants are known to have higher concentrations of natural chemical defences and a greater diversity than plants from any other biome, thus they are potential sources of new medicines [5] . Malaysia has the oldest tropical rainforest and a rich base of traditional medicine practices involving the use of plants [6] , many of which have yet to be subjected to rigorous scientific scrutiny to establish their medicinal value. The search for new anti-malarial drugs from plant sources based on their traditional use or ethnomedically data has proved to be a more predictive and promising approach when compared to random screening [7] . Goniothalamus lanceolatus (Bȃn) Mat Salleh, an endemic plant of Sarawak, Malaysia has been used traditionally by the indigenous communities. Decoction of leaves and stems are drunk to relieve colds and fever while the roots are boiled and used as a steam bath for skin diseases [8] . While there are no records of G. lanceolatus used for malaria, several studies on other Goniothalamus species, such as G. australis Jessup [9] , G. marcanii Craib [10] and G. scortechinii King [11] have shown significant activities against malarial parasites. Herein, the in vivo antimalarial potential and acute toxicity effects of crude extracts from the stembarks, leaves and roots of G. lanceolatus are reported.
During acute toxicity test, no mortality was recorded in mice given intraperitoneal injection of MeOH and DCM extracts of the stem bark and leaves at the dose of 300 mg/kg body weight. The mice did not show remarkable behavioural changes during the experimental period. However, for the root extracts, 83.3% mortality rates were recorded. Behavioural signs of toxicity, including paw licking, salivation and reduced activity were observed in these mice after 1 hour administration. [12] .
With the exception of DCM root and MeOH leaves, the other extracts increased the mean survival time of infected mice as compared to the negative control, although not in a statistically significant manner. The chloroquine treated mice survived for 7±0.9 days while the negative control treated mice survived for 4±1.2 days. The DCM stem bark extract showed the best parasitemia suppressive activity (66.3%), and it increased the survival time (to 6±2.1 days) of infected mice as compared to other tested extracts. This extract also did not show any toxic effects since doses up to 300 mg/kg do not resulted in mortality or alter the behavior of the tested mice. It can be extrapolated that the median lethal dose (LD 50 ) is thus greater than 300 mg/kg.
The present results indicate that the DCM extract of the stem bark of G. lanceolatus demonstrated most potential antiplasmo-dial activity against P. berghei infection in mice as evidenced by the percentage of inhibition of parasite development and the increase in the mean survival time of infected mice.
The phytochemical analysis of this extract indicates presents of styryllactone type of compounds as evident by the 1 H NMR spectra (Figure 1 ). The spectrum showed major proton signals at δ7.33-7.42, δ6.00, δ6.93, δ4.80, δ3.72, δ4.95, δ2.17 and δ2.78, indicating a major component, goniodiol 1. The HPLC profile of the crude extract ( Figure 2 ) showed presence of the major component as well as several other minor constituents. From the mass data (Table 2) , four more styryllactones were identified as 8-epi-9deoxygoniopypyrone 2 [13] , 9-deoxygoniopypyrone 3 [14] , digoniodiol 4 [15] and goniothalamin 5 [16] . Goniothalamin has been reported to possess antimalarial activity. Oral treatment with 30mg/kg of goniothalamin isolated from G. scortechinii suppressed 24.0% and 27.8% of both P. berghei and P. yoelii infected mice, respectively [17] .
However, it is worthy to note that even though goniothalamin is present in the DCM extract of G. lanceolatus bark reported in this In vivo antimalarial and toxicology of Goniothalamus lanceolatus Natural Product Communications Vol. 12 (8) 
Acute toxicity study: The acute toxicity of the extracts were assessed by determining the median lethal dose (LD 50 ) using the OECD Guideline 423 [18] . The animals were allowed to acclimatize for seven days before the commencement of the experiment. The mice (3 males and 3 females for each group) were divided into control and treatment groups. All groups were kept under observation for 14 days after the intraperitoneal administration of 5% Tween 60 (the control group) and a single dose (300 mg/kg) of the DCM extract of the stem bark, leaves, roots, and the MeOH extracts of the roots and leaves of G. lanceolatus in 5% Tween 60 (the treatment groups). The mice were observed for signs of toxicity after treatment for the first six hours and daily for a period of 14 days. Surviving animals were weighed and visual observations for mortality, behavioral pattern, changes in physical appearance, injury, pain and signs of illness were conducted daily during the period. The in vivo antimalarial testing was carried out using the classical four-day suppressive test against P. berghei (ANKA) as described by [19] . The mice were inoculated by the intraperitoneal (i.p.) route with 10 7 P. berghei infected red blood cells, and randomly divided into seven groups of three mice per cage. Chloroquine (reference drug) and 5% Tween 60 were used as positive and negative controls, respectively. The test extracts and chloroquine were administered as a single dose (30 mg/kg) starting 4 h after infection, and observations were continued daily for four consecutive days. All sample extracts and reference drug were injected as a suspension in 5% Tween 60 saline. Survival of mice was recorded daily. Percentage of parasitemia was determined microscopically (magnification, x 1,000) from mouse tail thin blood smears that were fixed with methanol and stained with Giemsa stain. Percentage parasitemia was determined by counting the infected erythrocytes in at least 1000 total erythrocytes (infected plus no (n-infected erythrocytes). The mean percentage suppression of parasitemia for each extract was calculated as follows: %suppression = %parasitemia control -% parasitemia in treated group x 100 %parasitemia control Phytochemical Analysis: The 1D and 2D NMR spectra were recorded in CDCl 3 on Bruker Ascend™ 600 MHz and Bruker Ultrashield™ Plus 500MHz spectrometers. Chemical shifts were reported in δ ppm scale and coupling constants were given in Hz. Analytical HPLC were performed on an AGILENT HPLC 1100 series system, equipped with Diode Array Detector 1200 series (G1315B), Micro degasser (G1379A) and quaternary pump (G1311A) with a C18 reversed phase column Sunfire 5µm (4.6x250 mm). Mass spectroscopic data were measured by LC/MSD Q-TOF connected to HPLC system (Agilent Technology HPLC 1200 Binary Pump SL), equipped with degasser, high performance automated liquid sampler (HiP-ALS SL), temperature controlled column compartment (TCC SL) and mass detector (Agilent Technologies 6520 Accurate-Mass Q-TOF).
Statistical Analysis:
Comparison of the mean between each experimental group with control groups was analyzed by one factor ANOVA. P-values of 0.05 or less were considered statistically significant.
